These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3692611

  • 1. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
    Heizmann W, Heilmann F, Werner H.
    Infection; 1987; 15(5):370-4. PubMed ID: 3692611
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR, Heilmann F, Werner H.
    Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [Abstract] [Full Text] [Related]

  • 4. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
    Leone F, Morandotti MG, Mazzella P, Sanna A, Ravizzola G, Colombrita D, Pinzi G, Turano R, Menozzi MG, Lecchini R.
    J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H, Heizmann W, Luft G.
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In-vitro activity of ampicillin/sulbactam against cefoxitin-resistant anaerobic bacteria.
    Jones RN, Barry AL.
    J Antimicrob Chemother; 1988 Jan; 21(1):135-8. PubMed ID: 3356620
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM, Goldstein EJ, Kenner MA, Burnham LB, Inderlied CB.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [Abstract] [Full Text] [Related]

  • 12. The effect of a combination of ampicillin and sulbactam against clinical isolates of anaerobic bacteria.
    Werner H, Heizmann W, Heilmann F.
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S27-30. PubMed ID: 18611716
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U, Manncke B, Gerbracht K, Werner H.
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB, Bartelt MA, Chan EL, Dalton HP.
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [Abstract] [Full Text] [Related]

  • 18. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM, Harris B, Carter WT, Finegold SM.
    Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.